SciELO - Scientific Electronic Library Online

 
vol.85 número4Frequency and clinical association of NY-ESO-1 gene expression in diffuse large B-cell lymphomaHelical tomotherapy: advanced radiotherapy technology índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Revista médica del Hospital General de México

versión On-line ISSN 2524-177Xversión impresa ISSN 0185-1063

Resumen

HIGUERA-DE LA TIJERA, Fátima; SERVIN-CAAMANO, Alfredo  y  PEREZ-HERNANDEZ, José L.. Gastrointestinal symptoms and disorders related to COVID-19. Lessons learned from gastroenterologists. Rev. med. Hosp. Gen. Méx. [online]. 2022, vol.85, n.4, pp.169-178.  Epub 23-Ene-2023. ISSN 2524-177X.  https://doi.org/10.24875/hgmx.22000013.

COVID-19 is mainly a respiratory illness caused by the SARS-CoV-2 but can also lead to GI symptoms. The primary host receptor which mediates the mechanism as SARS-CoV-2 enters the cell is the ACE2 receptor. Therefore, GI symptoms can be common in COVID-19, and in some cases, they are the first manifestation even before fever and respiratory symptoms. In addition, the liver function tests alteration often is related to a worse prognosis. The exact incidence of GI symptoms is a matter of debate. Moreover, wide variation concerning GI symptoms frequency exists, but the predominant ones seem to be diarrhea, anorexia, nausea, vomiting, and abdominal pain or discomfort. This review summarizes the most relevant findings of COVID-19 on the digestive system, including the liver, biliary tract, pancreas, the most common GI symptoms, and the atypical clinical GI manifestations.

Palabras llave : Coronavirus disease 2019; Severe acute respiratory syndrome coronavirus 2; Gastrointestinal symptoms; Pancreatitis; Liver injury; Gastrointestinal bleeding.

        · texto en Inglés     · Inglés ( pdf )